VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV), dedicated to developing innovative cancer therapies targeting DNA-damage response (DDR), is excited to announce a collaboration with Variational AI, known for its advanced… Read More
UBC researchers at Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) have been awarded more than $31.4 million in provincial funding for three projects that will accelerate the development of advanced vaccines and therapeutics… Read More
NORTH CHICAGO, ILL – AbbVie (NYSE: ABBV) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing… Read More
Vancouver, BC, Toronto, ON, & Montreal, QC – adMare BioInnovations (adMare) is pleased to announce the appointment of Dr. Marc Rivière to its Board of Directors. With extensive expertise in funding… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high… Read More
